CLOs on the Move


 
Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
  • Number of Employees: 10K-50K
  • Annual Revenue: > $1 Billion
  • www.baxter.com
  • 1 Baxter Parkway
    Deerfield, IL USA 60015
  • Phone: 800.422.9837

Executives

Name Title Contact Details
Edward Ryan
Sr. Dir, IT, Office of CIO Profile
Annlea Rumfola
EVP, Chief Information Officer Profile
Heather Knight
Chief Operating Officer Profile
Chris Toth
Chief Executive Officer Profile
Carl Jenkins
Associate General Counsel, Legal-Regulatory Profile

Similar Companies

Spartan Bioscience

Spartan Bioscience Inc. is a Nepean, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Bright Dental USA

Bright Dental USA is a Glenview, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ForTec Companies

ForTec Companies is a Streetsboro, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Integrity Applications

Integrity Applications is dedicated to developing breakthrough innovations in non-invasive glucose monitoring devices. Since its founding in 2001, Integrity Applications has been committed to improving the quality of life for people with diabetes by removing the obstacles of traditional invasive devices, namely painful pricking of fingertips, added costs as a result of disposables, as well as inconvenience. Integrity Applications has developed a state-of-the-art way to measure glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic in combination with a proprietary algorithm to produce a weighted glucose measurement. After proof of concept in 2002, Integrity Applications developed the first working prototype, GlucoTrack in August 2003. GlucoTrack® Model DF-F received CE Mark approval in June 2013 and KFDA in March 2016. GlucoTrack is currently being marketed in the European Union and in South Korea.

Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,400 people across 40 countries.